Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Rondecabtagene autoleucel, an autologous, dual-targeting CD19/CD20 CAR T-cell candidate manufactured from CD62L+ enriched T cells, achieves durable responses in patients with large B-cell lymphoma

Sarah Larson, Umar Farooq, Tahir Latif, Felix Mensah, Bradley Hunter, Stefan Ciurea, Nebu Koshy, Locke Bryan, Boyu Hu, William Clark, Hassaan Yasin, Yeonhee Kim, Greg Kaufman, Akil Merchant

Blood (2025) 146 (Supplement 1): 668.

https://doi.org/10.1182/blood-2025-668

Published: 2025

Journal Articles

Comparative outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis

Chalothorn Wannaphut, Piyatida Chumnumsiriwath, Stefan Ciurea, Piyanuch Kongtim

Blood (2025) 146 (Supplement 1): 2425.

https://doi.org/10.1182/blood-2025-2425

Published: 2025

Journal Articles

Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data

Piyanuch Kongtim, Andrew Portuguese, Soyoung Kim, Andrew Peterson, Hany Elmariah, Lori Muffly, Mark Juckett, Michael Grunwald, Mariam Nawas, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Xia Bi, Ryan Stubbins, Wael Saber, Stefan Ciurea, Bart Scott

Blood (2025) 146 (Supplement 1): 109.

https://doi.org/10.1182/blood-2025-109

Published: 2025

Journal Articles

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Monzr M. Al Malki, Corey Cutler, Ronald Sobecks, Iskra Pusic, Nelli Bejanyan, Sagar Patel, Arpita Gandhi, Vamsi Kota, Nabeel Rajeh, Piyanuch Kongtim, Chun-Po Fan, Yangyang Hao, Evgeniya Vaskova, Natali Gulbahce, Ashish Kothari, Nishant Dwivedi, Robert Woodward, Ran Reshef, Stefan Ciurea

Blood (2025) 146 (Supplement 1): 4301.

https://doi.org/10.1182/blood-2025-4301

Published: 2025

Journal Articles

Blinatumomab before and after allogeneic hematopoietic stem cell transplantation in adult patients with B-cell acute lymphoblastic leukemia

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Kiran Naqvi, Benjamin Lee, Jean Doh, Shawn Griffin, Jeffrey Kuo, Jeremy Harris, Piyanuch Kongtim, Stefan Ciurea

Blood (2025) 146 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2025-2520

Published: 2025

Journal Articles

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin J. Lee, Jean Doh, Shawn Griffin, Richard A. Van Etten, Piyanuch Kongtim, Stefan Ciurea

Blood (2023) 142 (Supplement 1): 2192.

https://doi.org/10.1182/blood-2023-190530

Published: 2023

Journal Articles

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Ashish S Kothari, Nishant Dwivedi, Camila Egidio, Mingwei Fei, Allison Bell, Piyanuch Kongtim, Marica Grskovic, Stefan Ciurea

Blood (2022) 140 (Supplement 1): 13005–13006.

https://doi.org/10.1182/blood-2022-170443

Published: 2022

Journal Articles

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Blood (2021) 137 (23): 3291–3305.

https://doi.org/10.1182/blood.2020009362

Published: 2021

Includes: Supplemental data

Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-139325

Published: 2020

Journal Articles

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-139283

Published: 2020

Journal Articles

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Neeraj Saini, David Marin, Celina Ledesma, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Qaiser Bashir, Chitra M. Hosing, Yago Nieto, Amin M. Alousi, Muzaffar H. Qazilbash, Stefan Ciurea, Elizabeth Shpall, Issa Khouri, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Richard E. Champlin, Partow Kebriaei

Blood (2020) 136 (15): 1786–1789.

https://doi.org/10.1182/blood.2019004685

Published: 2020

Includes: Supplemental data

Journal Articles

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Blood (2018) 131 (11): 1248–1257.

https://doi.org/10.1182/blood-2017-07-798751

Published: 2018

Includes: Supplemental data

Journal Articles

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Blood (2017) 130 (9): 1156–1164.

https://doi.org/10.1182/blood-2017-03-772368

Published: 2017

Includes: Supplemental data

Journal Articles

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Blood (2016) 127 (7): 938–947.

https://doi.org/10.1182/blood-2015-09-671834

Published: 2016

Includes: Supplemental data

Journal Articles

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

Blood (2015) 125 (19): 2885–2892.

https://doi.org/10.1182/blood-2015-01-607366

Published: 2015

Journal Articles

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

Issa F. Khouri, Wei Wei, Martin Korbling, Francesco Turturro, Sairah Ahmed, Amin Alousi, Paolo Anderlini, Stefan Ciurea, Elias Jabbour, Betul Oran, Uday R. Popat, Gabriela Rondon, Roland L. Bassett, Jr, Alison Gulbis

Blood (2014) 124 (14): 2306–2312.

https://doi.org/10.1182/blood-2014-07-587519

Published: 2014

Journal Articles

Nonmyeloablative allogeneic transplantation with or without 90 yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

Blood (2012) 119 (26): 6373–6378.

https://doi.org/10.1182/blood-2012-03-417808

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: PK Guided IV Busulfan Dose Intensity Results in Improved Event Free Survival

Uday Popat, M.D., Borje S Andersson, MD, PhD, Roland Bassett, Stefan Ciurea, Gabriela Rondon, MD, Amin M Alousi, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Yago Nieto, MD, PhD, Issa Khouri, MD, Elizabeth J Shpall, MD, Srdan Verstovsek, MD, PhD, Muzaffar Qazilbash, MD, Marcos J de Lima, MD, Richard Champlin, MD

Blood (2011) 118 (21): 2006.

https://doi.org/10.1182/blood.V118.21.2006.2006

Published: 2011

Journal Articles

Reduced Intensity Conditioning Combined with Post-Transplant Cyclophosphamide for Graft Vs. Host Disease Prophylaxis In Older-Aged or Medically Frail Patients with Advanced Hematological Malignancies

Amin M Alousi, MD, Borje S. Andersson, MD, Rima M. Saliba, PhD, Wendeline Botnick, RN, JD, Gabriela Rondon, MD, Elizabeth J. Shpall, MD, Marcos de Lima, MD, Uday Popat, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Issa Khouri, MD, Muzaffar H. Qazilbash, MD, Paolo Anderlini, MD, Yago Nieto, MD, PhD, Stefan Ciurea, MD, Roy Jones, MD, Richard Champlin

Blood (2010) 116 (21): 2341.

https://doi.org/10.1182/blood.V116.21.2341.2341

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis.

Uday Popat, Gabriela Rondon, Amin Alousi, MD, Paolo Anderlini, Borje Andersson, Chitra Hosing, Marcos de Lima, MD, Stefan Ciurea, Sergio Giralt, Partow Kebriaei, Yago Nieto, Issa Khouri, Muzaffar H Qazilbash, Roy Jones, Richard Champlin, MD

Blood (2009) 114 (22): 2283.

https://doi.org/10.1182/blood.V114.22.2283.2283

Published: 2009

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Rondecabtagene autoleucel, an autologous, dual-targeting CD19/CD20 CAR T-cell candidate manufactured from CD62L+ enriched T cells, achieves durable responses in patients with large B-cell lymphoma

Comparative outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis

Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Blinatumomab before and after allogeneic hematopoietic stem cell transplantation in adult patients with B-cell acute lymphoblastic leukemia

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

Nonmyeloablative allogeneic transplantation with or without 90 yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: PK Guided IV Busulfan Dose Intensity Results in Improved Event Free Survival

Reduced Intensity Conditioning Combined with Post-Transplant Cyclophosphamide for Graft Vs. Host Disease Prophylaxis In Older-Aged or Medically Frail Patients with Advanced Hematological Malignancies

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only